| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 135, 1576-1583, Copyright © 1994 by Endocrine Society
ARTICLES |
N Boujrad, JL Gaillard, M Garnier and V Papadopoulos
Department of Cell Biology, Georgetown University Medical Center, Washington, D.C. 20007.
We previously demonstrated that the mitochondrial peripheral-type benzodiazepine receptor (PBR) is coupled to hormone-activated steroidogenesis by regulating the intramitochondrial cholesterol transport, the rate-determining step of steroid biosynthesis. In the present study we examined whether PBR is the site of hormone action using the hCG-responsive MA-10 mouse Leydig tumor cell line as a model system. Within 15 sec of the addition of hCG to Leydig cells a 3-fold cAMP-dependent increase in PBR binding was observed. This rapid increase returned to basal levels within 60 sec. No effect was observed after 1 min in the continued presence of hCG. Scatchard analysis revealed that in addition to the known high affinity (5.0 nM) benzodiazepine-binding site, a second, hormone-induced, higher affinity (0.2 nM) benzodiazepine-binding site appeared. We then examined whether in such a short time frame steroid synthesis occurs. Fifteen-second incubation of MA-10 cells with the inhibitor of cholesterol metabolism aminoglutethimide together with hCG also resulted in an increased rate of pregnenolone formation by their isolated mitochondria that were washed and incubated in aminoglutethimide-free buffer. The dose response of benzodiazepine binding to hCG closely parallels the increase in steroid formation by the mitochondria of stimulated cells. Addition of the selective inhibitor of cAMP-dependent protein kinase, H- 89, completely blocked hormone-induced PBR binding and steroid formation, whereas addition of the inactive analog H-85 was without any effect. The addition of flunitrazepam, a benzodiazepine previously shown to inhibit the trophic hormone action on steroidogenesis, completely abolished the hCG-induced rapid stimulation of steroid synthesis. These results demonstrate that in MA-10 cells, the most rapid effect described thus far of hCG and cAMP, is the transient induction of a higher affinity benzodiazepine-binding site, which occurs concomitantly with an increase in the rate of steroid formation. This, in turn, suggests that these hormones alter PBR to activate cholesterol delivery to the inner mitochondrial membrane and subsequent steroid formation.
This article has been cited by other articles:
![]() |
T. Hauet, Z.-X. Yao, H. S. Bose, C. T. Wall, Z. Han, W. Li, D. B. Hales, W. L. Miller, M. Culty, and V. Papadopoulos Peripheral-Type Benzodiazepine Receptor-Mediated Action of Steroidogenic Acute Regulatory Protein on Cholesterol Entry into Leydig Cell Mitochondria Mol. Endocrinol., February 1, 2005; 19(2): 540 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, H. Amri, H. Huang, C. Wu, and V. Papadopoulos Gene and Protein Profiling of the Response of MA-10 Leydig Tumor Cells to Human Chorionic Gonadotropin J Androl, November 1, 2004; 25(6): 900 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. TASKEN and E. M. AANDAHL Localized Effects of cAMP Mediated by Distinct Routes of Protein Kinase A Physiol Rev, January 1, 2004; 84(1): 137 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gazouli, Z.-X. Yao, N. Boujrad, J. C. Corton, M. Culty, and V. Papadopoulos Effect of Peroxisome Proliferators on Leydig Cell Peripheral-Type Benzodiazepine Receptor Gene Expression, Hormone-Stimulated Cholesterol Transport, and Steroidogenesis: Role of the Peroxisome Proliferator-Activator Receptor {alpha} Endocrinology, July 1, 2002; 143(7): 2571 - 2583. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Culty, L. Luo, Z.-X. Yao, H. Chen, V. Papadopoulos, and B. R. Zirkin Cholesterol Transport, Peripheral Benzodiazepine Receptor, and Steroidogenesis in Aging Leydig Cells J Androl, May 1, 2002; 23(3): 439 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, B. Degenhardt, D. Tobin, Z.-x. Yao, K. Tasken, and V. Papadopoulos Identification, Localization, and Function in Steroidogenesis of PAP7: A Peripheral-Type Benzodiazepine Receptor- and PKA (RI{alpha})-Associated Protein Mol. Endocrinol., December 1, 2001; 15(12): 2211 - 2228. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Boujrad, B. Vidic, M. Gazouli, M. Culty, and V. Papadopoulos The Peroxisome Proliferator Perfluorodecanoic Acid Inhibits the Peripheral-Type Benzodiazepine Receptor (PBR) Expression and Hormone-Stimulated Mitochondrial Cholesterol Transport and Steroid Formation in Leydig Cells Endocrinology, September 1, 2000; 141(9): 3137 - 3148. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zilz, H. Li, R. Castello, V. Papadopoulos, and E. P. Widmaier Developmental Expression of the Peripheral-Type Benzodiazepine Receptor and the Advent of Steroidogenesis in Rat Adrenal Glands Endocrinology, February 1, 1999; 140(2): 859 - 864. [Abstract] [Full Text] |
||||
![]() |
L. Luo, H. Chen, D. M. Stocco, and B. R. Zirkin Leydig Cell Protein Synthesis and Steroidogenesis in Response to Acute Stimulation by Luteinizing Hormone in Rats Biol Reprod, August 1, 1998; 59(2): 263 - 270. [Abstract] [Full Text] |
||||
![]() |
N. Ariyoshi, Y.-C. Kim, I. Artemenko, K. K. Bhattacharyya, and C. R. Jefcoate Characterization of the Rat Star Gene That Encodes the Predominant 3.5-Kilobase Pair mRNA. ACTH STIMULATION OF ADRENAL STEROIDS IN VIVO PRECEDES ELEVATION OF Star mRNA AND PROTEIN J. Biol. Chem., March 27, 1998; 273(13): 7610 - 7619. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Papadopoulos, H. Amri, H. Li, N. Boujrad, B. Vidic, and M. Garnier Targeted Disruption of the Peripheral-type Benzodiazepine Receptor Gene Inhibits Steroidogenesis in the R2C Leydig Tumor Cell Line J. Biol. Chem., December 19, 1997; 272(51): 32129 - 32135. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Amri, K. Drieu, and V. Papadopoulos Ex Vivo Regulation of Adrenal Cortical Cell Steroid and Protein Synthesis, in Response to Adrenocorticotropic Hormone Stimulation, by the Ginkgo biloba Extract EGb 761 and Isolated Ginkgolide B Endocrinology, December 1, 1997; 138(12): 5415 - 5426. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |